ASTM-F1634 Historical Revision Information
Standard Practice for In-Vitro Environmental Conditioning of Polymer Matrix Composite Materials and Implant Devices

ASTM-F1634 - 1995 R00 EDITION - SUPERSEDED
Show Complete Document History

Document Center Inc. is an authorized dealer of ASTM standards.
The following bibliographic material is provided to assist you with your purchasing decision:

Standard Practice for In-Vitro Environmental Conditioning of Polymer Matrix Composite Materials and Implant Devices (Withdrawn 2017)
ORDER

Scope

1.1 This practice covers two procedures for conditioning non-absorbable polymer matrix composite (PMC) materials and implant devices in a liquid environment to obtain a state of saturation.

1.2 The purpose of this practice is to standardize methods and reporting procedures for conditioning PMC materials and implant devices (PMC specimens) in a user selected liquid environment prior to conducting subsequent tests. It is not the purpose of this practice to determine the diffusion coefficients or actual saturation levels of a given liquid into the materials and devices. For these determinations, other procedures, such as Test Method D 5229, may be followed.

1.3 Diffusion of liquid into a solid material is a slow process. While the time necessary to achieve saturation at 37°C may be sufficiently short for thin specimens, such as fracture fixation plates, it may be prohibitively long in thick sections, such as femoral components for hip arthroplasty. However, the diffusion process may be accelerated at an elevated temperature. Consequently, two separate procedures (Procedures A and B) are presented in this practice. Procedure A covers exposing the specimen to the desired conditioning environment at 37°C. Procedure B prescribes a method to accelerate the diffusion process by conditioning the specimen at a selected elevated temperature.

1.4 This practice does not specify the test environment to be used for conditioning. However, the pH value of immersion liquid shall be maintained at 7.4 ± 0.2 to simulate the in vivo environment.

1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.

Significance and Use

The conditioning procedures covered in this practice provide methods for saturating PMC specimens in a liquid environment prior to conducting other tests for property evaluation.

The conditioning may affect geometric and dimensional changes in specimens. In some severe cases, chemical changes may occur in the fiber, polymer and fiber-polymer interphase and interface.

Caution must be taken if Procedure B (10.2, Procedure BAccelerated Moisture Saturation at Elevated Temperature) is followed to condition PMC specimens at an elevated temperature. Physical and chemical reactions in materials are normally temperature dependent. An increase in experimental temperature may accelerate a desirable moisture diffusion process. However, elevated temperatures above 37°C may also cause undesirable reactions that do not represent appropriate responses of materials at 37°C. Consequently, a pilot study is recommended in Procedure B to determine if a selected elevated temperature can be used for accelerated conditioning. If the properties of materials are determined to be irreversibly affected by this pilot study at the selected elevated temperature, then either an appropriate lower elevated temperature should be determined by repeating the pilot study, or Procedure B should not be used.

Keywords

accelerated conditioning; composite; diffusion; environmental conditioning; fiber; implant devices; moisture absorption; polymer; ICS Number Code 11.040.40 (Implants for surgery, prothetics and orthotics)

To find similar documents by ASTM Volume:

13.01 (Medical and Surgical Materials and Devices)

To find similar documents by classification:

11.040.40 (Implants for surgery, prosthetics and orthotics Including pacemakers Ophthalmic implants, see 11.040.70)

This document comes with our free Notification Service, good for the life of the document.

This document is available in either Paper or PDF format.

Document Number

ASTM-F1634-95(2000)

Revision Level

1995 R00 EDITION

Status

Superseded

Publication Date

Nov. 10, 1995

Document Type

Practice

Page Count

5 pages

Committee Number

F04.15